Pulmonx Corporation (LUNG)
NASDAQ · Healthcare
Pulmonx Corporation Revenue 2020–2025
Pulmonx Corporation annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Pulmonx Corporation revenue for the quarter ending March 31, 2026 was 20.6 M.
- Pulmonx Corporation revenue for the twelve months ending March 31, 2026 was 88.5 M.
- Pulmonx Corporation annual revenue for 2025 was 90.5 M, a 8.01% increase from 2024.
- Pulmonx Corporation annual revenue for 2024 was 83.8 M, a 22.01% increase from 2023.
- Pulmonx Corporation annual revenue for 2023 was 68.7 M, a 27.98% increase from 2022.
- Pulmonx Corporation annual revenue for 2022 was 53.7 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Pulmonx Corporation Earnings — FAQ
Pulmonx Corporation (LUNG) earnings over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LUNG's earnings history?
The chart and table above show Pulmonx Corporation's earnings by year and by quarter, including the growth rate.